pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,854 catalysts · 18,987 approval · 5,539 phase readout · 5,000 device 510k · 4,728 grant · 2,701 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 47 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: recall×type: grant×clear all
type
  • approval18,987
  • phase readout5,539
  • device 510k5,000
  • grant4,728
  • 8k filing2,701
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • pdufa347
  • therapy area

    no tagged catalysts yet

    Week of Sep 15, 2025

    50
    ›Sep 16, 2025grant323d agoUNIVERSITY OF PENNSYLVANIA — Nuclear Localization and Function of the Ebola Virus VP40 ProteinUniversity of Pennsylvania

    AI grant. $446,875. PI: RONALD N HARTY

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoHARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH — Ambient Particle Radioactivity and Lung Cancer Survival

    ES grant. $433,185. PI: David C Christiani

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Blood Brain Barrier Dysfunction in Chronic Alcohol Use Disorder

    AA grant. $410,413. PI: DAVID HAROLD ZALD

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoUNIVERSITY OF MARYLAND BALTIMORE — Cross-disciplinary approach to understanding the long-term impact of HIV expo...

    HD grant. $276,979. PI: Arox Wadson Kamng'ona

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoOHIO STATE UNIVERSITY — Air Pollution Effects on Child Irritability and Brain Connectivity

    ES grant. $200,680. PI: Mariah DeSerisy

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoUNIVERSITY OF ARIZONA — A Novel RAD51-BRCA2 Complex Stabilizing Drug: A Medical Countermeasure for Mi...

    AI grant. $583,468. PI: Mahmoud Salama Ahmed

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoTOIVOA, INC — Development of an accessible Cognitive Behavioral Therapy digital therapeutic...

    NR grant. $383,159. PI: Laura Randa

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoFISHER BIOSERVICES, INC. — NICHD BIOSPECIMEN REPOSITORY SERVICES FOR LEGACY COLLECTION

    HD grant. $691,294. PI: BRITTANY MARTIN

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Investigation of NRG1 functions in endocardial cushion development in the heartAlbert Einstein College of Medicine

    HL grant. $49,538. PI: Gloria Andreeva Stoyanova

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoMAKERERE UNIVERSITY LUNG INSTITUTE LIMITED — Clonotyping Airway T-cells to Uncover Microbiome-Specific Inflammotypes in HI...

    TW grant. $124,524. PI: Alex Kayongo

    full page →nih reporter ↗
    ›Sep 16, 2025grant323d agoUNIVERSITY OF WASHINGTON — Visual Olfactory Learning in MosquitoesUniversity of Washington

    AI grant. $49,538. PI: Grace Emily Van Susteren

    full page →nih reporter ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1131-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1129-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-050-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoWorld Perfumes Inc. recall (Cls II)

    Iodo Blanco Iodides, First Aid Antiseptic, Mercury Free, Iodine 2%, First Aid Antiseptic, Contains 1 fl. oz (30 ml) per bottle, Distributed by: Essential Products, www.essentialproductsusa.com, NDC: 70242-109-01 — Reason: Defective Container: broken or leaking bottles. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoSandoz Inc recall (Cls II)Sandoz Inc

    Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 — Reason: Temperature Abuse — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-048-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1130-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoAvKARE recall (Cls II)AvKare LLC

    chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15 — Reason: Presence of a foreign substance. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-051-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-049-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoAvKARE recall (Cls II)AvKare LLC

    chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15 — Reason: Presence of a foreign substance. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoAtlantic Management Resources Ltd. recall (Cls II)

    Neuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901 Westboro, MA 01581 USA, NDC 66233712-01 — Reason: cGMP violations — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoGRACE & FIRE PTY LTD recall (Cls II)

    Ultra Violette Mini SPF Mates kit includes: Velvet Screen SPF 50 Blurring Mineral SkinScreen, Zinc Oxide 22.75%, 15 mL, 0.5 fl. oz. per tube, Supreme Sunscreen SPF 50, 15 mL 0.5 fl. oz. per tube, Distributed by: Grace & Fire USA Inc., 251 Little Falls Drive, New Castle Wilmington, Delaware 19808, NDC 84803-110-01 (15 mL Velvet Screen), UPC 9355909005757. — Reason: Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton). — Reason: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1132-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoGRACE & FIRE PTY LTD recall (Cls II)

    Ultra Violette, Velvet Screen SPF 50, Blurring Mineral Skinscreen, Zinc Oxide 22.75%, a) 15 mL, 0.5 fl. oz. per tube, NDC 84803-106-01, UPC 9355909006068, b) 50 mL, 1.7 fl. oz. per tube, NDC 84803-106-02, UPC 9355909005924, Distributed by: Grace & Fire USA Inc., 251 Little Falls Drive, New Castle Wilmington, Delaware 19808. — Reason: Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1133-1 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoExela Pharma Sciences LLC recall (Cls II)Exela Pharma Sciences LLC

    4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton) — Reason: Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoBreckenridge Pharmaceutical, Inc. recall (Cls II)Breckenridge Pharmaceutical Inc

    Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain. Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC: 82009-030-10 — Reason: CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls II)CARDINAL HEALTH INC

    Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per bag, Rx only, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters). — Reason: Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-047-01 — Reason: CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoLannett Company Inc. recall (Cls II)Lannett Co Inc

    Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100 Tablets per bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-0762-37. — Reason: Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg. — Status: Completed

    full page →fda recalls ↗
    ›Sep 17, 2025recall322d agoThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls II)Novel Laboratories Inc

    Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61 — Reason: Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 17, 2025grant322d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Alcohol taxation, policy environment, and alcohol health services

    AA grant. $1,742,166. PI: Ziming Xuan

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF SOUTHERN CALIFORNIA — New low cost technology for early detection of ear disordersUniversity of Southern California

    DC grant. $445,861. PI: Brian E. Applegate

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoNORTHERN CALIFORNIA INSTITUTE/RES/EDU — PRG4/Lubricin glycoform variants associated with endocardial infections and s...

    AI grant. $448,375. PI: Barbara Anne Bensing

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoINTEGRATED MEDICAL SENSORS — A Miniaturized and Flexible Continuous Glucose Monitoring Platform

    DK grant. $275,275. PI: Muhammad Mujeeb-U-Rahman

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF WASHINGTON — Leveraging Integrated liNked data to assess and optimize Child outcomes (LINC)University of Washington

    HD grant. $43,376. PI: Cyrus Mugo Wachira

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — P30 - Core Grant for Vision ResearchUniversity of California San Francisco

    EY grant. $699,202. PI: Erik M Ullian

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoCRYOCRATE, LLC — Novel Biocompatible, High-Throughput Cryopreservation Medium and Method for E...

    CA grant. $292,963. PI: Xu Han

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoDREXEL UNIVERSITY — Improving Health Through HUD Housing Assistance for Chronic Disease Care

    NR grant. $3,726,027. PI: Lindsay Lawer Shea

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoNEURALTHREAD INC — TulleKit: Integrated Deep Brain Neural Recording System for Non-Human Primate...

    MH grant. $980,661. PI: Joseph Novello

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoSYNTAXISBIO, INC. — Novel technologies for cellular age profiling and validation

    HG grant. $396,170. PI: ALEXANDER PERTSEMLIDIS

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF IOWA — DSHB Antibody Research, Production and Distribution FacilityUniversity of Iowa

    OD grant. $3,398,996. PI: DOUGLAS W HOUSTON

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoGEORGIA STATE UNIVERSITY — Investigating the sweet side of gonorrhea to understand nutrient acquisition ...

    AI grant. $227,601. PI: CYNTHIA N CORNELISSEN

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoFLORIDA ATLANTIC UNIVERSITY — Peripheral effectors in alcohol-induced stress-susceptibility and blood-brain...

    AA grant. $178,513. PI: Lyonna Francesca Parise

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF ARIZONA — Unveiling the gut's sensory code: Implications for food, development, and dis...

    DK grant. $1,276,640. PI: Melanie Maya Kaelberer

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Perceptual effects of processing and transmission delay in hearing technology

    DC grant. $567,771. PI: Ryan Michael Corey

    full page →nih reporter ↗
    ›Sep 17, 2025grant322d agoTUFTS UNIVERSITY BOSTON — Multiethnic and multiomics analysis of longitudinal changes in DNA methylatio...

    HL grant. $1,119,410. PI: Jiantao Ma

    full page →nih reporter ↗
    ← prev
    page 37 of 118
    next →
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $LBRX42.84+6.89%
    $CAH229.12-1.46%
    $LBRX42.84+6.89%